Heavy drinkers, or people who are dependent on alcohol, constantly need to detoxify their bodies to get rid of any poisons that alcohol intake may have left behind. This is significant because, if untreated, alcoholism can have serious repercussions. The alcohol detoxification programme is a crucial first step in the full process of medical treatment for alcohol withdrawal that is advised by the experts. Given the seriousness of alcoholism, which accounts for more than 100,000 fatalities annually in the United States alone, it is crucial that persons who are addicted to alcohol undergo a complete alcohol detoxification programme. Alcohol detoxification programmes can be conducted in a variety of locations. These include inpatient or outpatient treatments, residential rehab programmes for alcohol detox, partial hospitalisation or day treatment, outpatient programmes, and intense outpatient programmes for alcohol detox. Patients enrolled in hospital-based alcohol detox programmes are required to remain on the clinic grounds throughout their treatment. They are now very uncommon practices. In residential programmes, patients are kept in residential settings, almost shut off from all other friends, family, and relatives, in order to develop close relationships with people who are receiving treatment there as well. This aids individuals in overcoming their issues and the alcohol detoxification process gradually.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States